Atlanta, GA, United States of America

Renren Bai



Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Decatur, GA (US) (2020)
  • Atlanta, GA (US) (2020 - 2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Renren Bai: Innovator in CXCR4 Inhibition

Introduction

Renren Bai is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of pharmaceutical sciences. He holds three patents that focus on bis-amine compounds and their applications in CXCR4 inhibition. His work is crucial in the development of treatments for diseases related to CXCR4.

Latest Patents

Renren Bai's latest patents include innovative bis-amines and compositions related to CXCR4 inhibition. These disclosures detail bis-amine compounds and their uses in treating or preventing CXCR4-related diseases. The compounds are characterized by specific formulas and include salts, derivatives, and prodrugs. The patents also contemplate pharmaceutical compositions that utilize these compounds, providing a pathway for effective treatment options.

Career Highlights

Throughout his career, Renren Bai has worked with esteemed institutions such as Emory University and Georgia State University Research Foundation, Inc. His research has focused on the development of pharmaceutical solutions that address critical health issues.

Collaborations

Renren Bai has collaborated with notable colleagues, including Hyunsuk Shim and Suazette Reid Mooring. These partnerships have enhanced his research and contributed to the advancement of his innovative work.

Conclusion

Renren Bai's contributions to the field of pharmaceutical sciences, particularly in CXCR4 inhibition, highlight his role as a significant inventor. His patents and collaborations reflect his commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…